Portfolio (Quarterly)
Guide ↗
PSP Research LLC
· CIK 0002106939| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 41 | ELVN | ENLIVEN THERAPEUTICS INC | Healthcare | 7,000.0 | $355K | 0.19% | — | — | $50.75 | +14.0% |
| 42 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 4,000.0 | $355K | 0.19% | -1K | -22.5% | $88.78 | +1.8% |
| 43 | NTLA | INTELLIA THERAPEUTICS INC | Healthcare | 20,000.0 | $338K | 0.18% | -7K | -25.6% | $16.92 | -23.9% |
| 44 | MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | 600.0 | $322K | 0.17% | — | — | $536.95 | -0.6% |
| 45 | — | KINIKSA PHARMACEUTICALS INTL | — | 5,000.0 | $320K | 0.17% | -4K | -44.4% | $63.95 | — |
| 46 | ALKS | ALKERMES PLC | Healthcare | 6,000.0 | $314K | 0.17% | — | — | $52.40 | -9.5% |
| 47 | TNGX | TANGO THERAPEUTICS INC | Healthcare | 10,000.0 | $313K | 0.17% | -4K | -30.6% | $31.26 | -25.3% |
| 48 | ARDX | ARDELYX INC | Healthcare | 60,000.0 | $306K | 0.16% | -20K | -25.0% | $5.10 | -25.3% |
| 49 | VERA | VERA THERAPEUTICS INC | Healthcare | 7,000.0 | $300K | 0.16% | -3K | -30.0% | $42.91 | -20.3% |
| 50 | MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | 2,500.0 | $293K | 0.16% | -2K | -50.0% | $117.07 | -16.8% |
| 51 | ORKA | ORUKA THERAPEUTICS INC | Healthcare | 3,000.0 | $286K | 0.15% | -2K | -39.6% | $95.17 | -4.2% |
| 52 | SUPN | SUPERNUS PHARMACEUTICALS | Healthcare | 6,000.0 | $279K | 0.15% | — | — | $46.51 | -6.0% |
| 53 | CRSP | CRISPR THERAPEUTICS AG | Healthcare | 5,000.0 | $273K | 0.14% | -4K | -47.4% | $54.54 | +5.8% |
| 54 | — | ZYMEWORKS INC | — | 10,000.0 | $261K | 0.14% | — | — | $26.14 | — |
| 55 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 692.0 | $257K | 0.14% | NEW | — | $371.67 | -5.4% |
| 56 | CMPS | COMPASS PATHWAYS PLC | Healthcare | 18,000.0 | $255K | 0.14% | -53K | -74.7% | $14.15 | -3.0% |
| 57 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 4,200.0 | $254K | 0.14% | — | — | $60.36 | -0.6% |
| 58 | AXSM | AXSOME THERAPEUTICS INC. | Healthcare | 1,000.0 | $245K | 0.13% | -2K | -64.8% | $244.77 | -18.7% |
| 59 | AVBP | ARRIVENT BIOPHARMA INC | Healthcare | 7,041.0 | $245K | 0.13% | NEW | — | $34.74 | -13.2% |
| 60 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 2,500.0 | $244K | 0.13% | -2K | -50.0% | $97.48 | +8.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%